Cargando…

Ethanol exposure alters Alzheimer’s-related pathology, behavior, and metabolism in APP/PS1 mice

Epidemiological studies identified alcohol use disorder (AUD) as a risk factor for Alzheimer’s disease (AD), yet there is conflicting evidence on how alcohol use promotes AD pathology. In this study, a 10-week moderate two-bottle choice drinking paradigm was used to identify how chronic ethanol expo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Day, Stephen M., Gironda, Stephen C., Clarke, Caitlin W., Snipes, J. Andy, Nicol, Noelle I., Kamran, Hana, Vaughan, Warner, Weiner, Jeffrey L., Macauley, Shannon L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010148/ https://www.ncbi.nlm.nih.gov/pubmed/36535550 http://dx.doi.org/10.1016/j.nbd.2022.105967

Ejemplares similares

The Interaction Between Sleep and Metabolism in Alzheimer’s Disease: Cause or Consequence of Disease?
por: Carroll, Caitlin M., et al.
Publicado: (2019)

K(ATP) channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer’s disease–related pathology
por: Grizzanti, John, et al.
Publicado: (2023)

Altered dorsal CA1 neuronal population coding in the APP/PS1 mouse model of Alzheimer’s disease
por: Chockanathan, Udaysankar, et al.
Publicado: (2020)

Recent Advances from the Bench Toward the Bedside in Alzheimer's Disease
por: Macauley, Shannon L., et al.
Publicado: (2015)

Changes in insulin and insulin signaling in Alzheimer’s disease: cause or consequence?
por: Stanley, Molly, et al.
Publicado: (2016)

S-adenosylmethionine and S-adenosylhomocysteine levels in the aging brain of APP/PS1 Alzheimer mice
por: Hooijmans, Carlijn R., et al.
Publicado: (2009)

Disruption of hippocampal neuronal circuit function depends upon behavioral state in the APP/PS1 mouse model of Alzheimer’s disease
por: Zhou, Heng, et al.
Publicado: (2022)

Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012)

NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
por: Heneka, Michael T., et al.
Publicado: (2012)

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II
por: Ma, Tao, et al.
Publicado: (2023)

Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
por: Wirths, Oliver, et al.
Publicado: (2009)

Effect of ethanol and cocaine on [(11)C]MPC-6827 uptake in SH-SY5Y cells
por: Damuka, Naresh, et al.
Publicado: (2021)

Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A(2A) receptors
por: Viana da Silva, Silvia, et al.
Publicado: (2016)

Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice
por: Hiltunen, Mikko, et al.
Publicado: (2012)

Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
por: Webster, Scott J, et al.
Publicado: (2013)

Isolation Housing Exacerbates Alzheimer’s Disease-Like Pathophysiology in Aged APP/PS1 Mice
por: Huang, Huang, et al.
Publicado: (2015)

PT573. The effects of intestinal endotoxemia on APP, PS1 and BACE expression in Alzheimer’s disease
por: Han, Bai, et al.
Publicado: (2016)

Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
por: Zhang, Xueju, et al.
Publicado: (2020)

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model
por: Chen, Qingyou, et al.
Publicado: (2021)

Effects of multi-mode physical stimulation on APP/PS1 Alzheimer's disease model mice
por: Liu, Shupeng, et al.
Publicado: (2022)

Neuroprotective effects of resistance physical exercise on the APP/PS1 mouse model of Alzheimer’s disease
por: Campos, Henrique Correia, et al.
Publicado: (2023)

Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease
por: Woo, Ran-Sook, et al.
Publicado: (2011)

Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer’s Disease in APP+PS1 Mice
por: Nabar, Neel R., et al.
Publicado: (2012)

A Comparative Evaluation of a Novel Vaccine in APP/PS1 Mouse Models of Alzheimer's Disease
por: Carrera, Iván, et al.
Publicado: (2015)

An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model
por: Kempf, Stefan J., et al.
Publicado: (2016)

Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model
por: Park, Tae-Shin, et al.
Publicado: (2017)

Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice
por: Sun, Jing, et al.
Publicado: (2019)

Active compounds of herbs ameliorate impaired cognition in APP/PS1 mouse model of Alzheimer’s disease
por: Yu, WenJun, et al.
Publicado: (2019)

Accelerated Dystrophy and Decay of Oligodendrocyte Precursor Cells in the APP/PS1 Model of Alzheimer’s-Like Pathology
por: Chacon-De-La-Rocha, Irene, et al.
Publicado: (2020)

Ovocystatin Induced Changes in Expression of Alzheimer’s Disease Relevant Proteins in APP/PS1 Transgenic Mice
por: Stanczykiewicz, Bartlomiej, et al.
Publicado: (2022)

The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer’s disease
por: Tian, Yanna, et al.
Publicado: (2023)

Immune-mediated platelet depletion augments Alzheimer’s disease neuropathological hallmarks in APP-PS1 mice
por: de Sousa, Diana M. Bessa, et al.
Publicado: (2023)

Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer’s Disease Mouse Model: Role of Microglial and Neuroinflammation
por: Ma, Jing, et al.
Publicado: (2023)

Impact of Donepezil Supplementation on Alzheimer’s Disease-like Pathology and Gut Microbiome in APP/PS1 Mice
por: Li, Yuan, et al.
Publicado: (2023)

Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome
por: Day, Stephen M., et al.
Publicado: (2019)

Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
por: Teich, Andrew F., et al.
Publicado: (2018)

Immune senescence in aged APP/PS1 mice
por: Abdelmoaty, Mai M., et al.
Publicado: (2023)

Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice
por: Stojakovic, Andrea, et al.
Publicado: (2021)

Neuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
por: Faivre, Emilie, et al.
Publicado: (2013)

Taurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer's disease
por: Kim, Hye Yun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tl2ia750dtk73qfsa9110hgd5c